BioLife Solutions, Inc.

Equities

BLFS

US09062W2044

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:04 2024-07-12 pm EDT			5-day change	1st Jan Change
20.7 ^USD	-1.29%		+3.50%	+27.38%

May. 29	BioLife Solutions Introduces the CellSeal CryoCase? at International Society for Cell & Gene Therapies Conference in Vancouver	CI
May. 13	Benchmark Upgrades BioLife Solutions to Buy From Hold With $25 Price Target	MT

Biolife Solutions, Inc. Announces Termination of Joe Annicchiarico as Chief Operating Officer

January 21, 2016 at 12:28 pm EST

On January 15, 2016, BioLife Solutions, Inc. terminated the employment of Joe Annicchiarico, previously the company's chief operating officer. The Company anticipates that it will pay Mr. Annicchiarico three months's salary as severance pay.

Latest news about BioLife Solutions, Inc.

BioLife Solutions Introduces the CellSeal CryoCase? at International Society for Cell & Gene Therapies Conference in Vancouver	May. 29	CI
Benchmark Upgrades BioLife Solutions to Buy From Hold With $25 Price Target	May. 13	MT
Earnings Flash (BLFS) BIOLIFE SOLUTIONS Posts Q1 Revenue $31.7M, vs. Street Est of $24.9M	May. 09	MT
Transcript : BioLife Solutions, Inc., Q1 2024 Earnings Call, May 09, 2024	May. 09
BioLife Solutions, Inc. Affirms Revenue Guidance for the Year 2024	May. 09	CI
BioLife Solutions, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
BioLife Solutions Completes Divestment of Global Cooling Subsidiary	Apr. 18	MT
An undisclosed buyer entered into a Stock Purchase Agreement to acquire Global Cooling, Inc. from BioLife Solutions, Inc. for $2.6 million.	Apr. 17	CI
Jefferies Initiates Coverage on BioLife Solutions With Buy Rating, $22 Price Target	Apr. 04	MT
BioLife Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Transcript : BioLife Solutions, Inc., Q4 2023 Earnings Call, Feb 29, 2024	Feb. 29
BioLife Solutions, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Biolife Solutions Announces Preliminary Unaudited Revenue Results for Fourth Quarter and Full Year 2023	Jan. 08	CI
Lake Street Adjusts BioLife Solutions Price Target to $15 From $25, Maintains Buy Rating	Nov. 10	MT
Transcript : BioLife Solutions, Inc., Q3 2023 Earnings Call, Nov 09, 2023	Nov. 09
BioLife Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Casdin Capital Engages in Discussions with BioLife Solutions	23-10-24	CI
BioLife Solutions Names New CEO; Sees 2023 Revenue at Low End of Guidance	23-10-19	MT
BioLife Solutions, Inc. Announces Chief Executive Officer Changes	23-10-19	CI
BioLife Solutions, Inc. Announces Management Changes	23-10-19	CI
BioLife Solutions, Inc. Revises Earnings Guidance for the Full Year 2023	23-10-19	CI
BioLife Solutions, Inc. announced that it has received $10.374976 million in funding from Casdin Capital, LLC	23-10-18	CI
Lake Street Adjusts Price Target on BioLife Solutions to $25 From $34, Maintains Buy Rating	23-08-09	MT
Transcript : BioLife Solutions, Inc., Q2 2023 Earnings Call, Aug 08, 2023	23-08-08
Biolife Solutions, Inc. Provides Earnings Guidance for the Year 2023	23-08-08	CI

Chart BioLife Solutions, Inc.

Duration

Period

More charts

Company Profile

BioLife Solutions, Inc. is a supplier of cell processing tools and services for the cell and gene therapy (CGT) and broader biopharma markets. Its expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage and distribution. Its biopreservation media products, HypoThermosol FRS and CryoStor Freeze Media, are formulated to mitigate preservation-induced, delayed-onset cell damage and death which result when cells and tissues are subjected to reduced temperatures. Its bioproduction tools portfolio includes human platelet lysates for cell expansion. It is a provider of biological and pharmaceutical storage and cold chain logistics. Its monitoring systems allow customers real time tracking of the storage temperatures of their materials throughout the logistics process. It operates about five storage facilities in the United States and one facility in the Netherlands.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-21 - Annual General Meeting

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for BioLife Solutions, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

20.72 USD

Average target price

24.78 USD

Spread / Average Target

+19.58%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
BIOLIFE SOLUTIONS, INC.	+27.38%	955M
ABBOTT LABORATORIES	-5.31%	181B
MEDTRONIC PLC	-5.38%	99.95B
BECTON, DICKINSON AND COMPANY	-6.04%	66.21B
HOYA CORPORATION	+16.45%	45.4B
DEXCOM, INC.	-8.08%	45.36B
CENCORA, INC.	+8.38%	43.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+12.06%	29.03B
TERUMO CORPORATION	+17.98%	25.64B
WEST PHARMACEUTICAL SERVICES, INC.	-8.28%	23.53B

Other Medical Equipment, Supplies & Distribution